OFFICIAL PUBLICATION OF

by its subsidiary APPco

Posts in tag

naltrexone

Debbie Rigby takes a look at the latest in research news Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT) A 24-week randomised controlled, comparative effectiveness trial …

Recent Comments
Popular Posts

What does the future look like for CWH/Sigma shareholders?

Yeh but CWH's entire business model is to go to areas with low rent and charge below cost prescriptions and…

Bob Tran

What does the future look like for CWH/Sigma shareholders?

if they can't grow internally they can easily acquire other store and distribution centre and shareholder would be more than…

viknesh bramasta

What does the future look like for CWH/Sigma shareholders?

Ponraj unlike Coles CWH sell medications LOL - if they can't grow internally they can easily acquire other store and…

viknesh bramasta

What does the future look like for CWH/Sigma shareholders?

Undervalued. With the data Sigma have on your purchasing (even if not primary supplier), combined with what they receive from…

Justin Levine

naltrexone

Research Roundup

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Research Roundup

MENU

Hi there! 👋 Looks like you’re not logged in.